BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 31525912)

  • 1. Degronomics: Mapping the Interacting Peptidome of a Ubiquitin Ligase Using an Integrative Mass Spectrometry Strategy.
    Canzani D; Rusnac DV; Zheng N; Bush MF
    Anal Chem; 2019 Oct; 91(20):12775-12783. PubMed ID: 31525912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recognition of the Diglycine C-End Degron by CRL2
    Rusnac DV; Lin HC; Canzani D; Tien KX; Hinds TR; Tsue AF; Bush MF; Yen HS; Zheng N
    Mol Cell; 2018 Dec; 72(5):813-822.e4. PubMed ID: 30526872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying the substrate proteins of U-box E3s E4B and CHIP by orthogonal ubiquitin transfer.
    Bhuripanyo K; Wang Y; Liu X; Zhou L; Liu R; Duong D; Zhao B; Bi Y; Zhou H; Chen G; Seyfried NT; Chazin WJ; Kiyokawa H; Yin J
    Sci Adv; 2018 Jan; 4(1):e1701393. PubMed ID: 29326975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomics strategy to identify substrates of LNX, a PDZ domain-containing E3 ubiquitin ligase.
    Guo Z; Song E; Ma S; Wang X; Gao S; Shao C; Hu S; Jia L; Tian R; Xu T; Gao Y
    J Proteome Res; 2012 Oct; 11(10):4847-62. PubMed ID: 22889411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ubiquitin binding domain ZnF UBP recognizes the C-terminal diglycine motif of unanchored ubiquitin.
    Reyes-Turcu FE; Horton JR; Mullally JE; Heroux A; Cheng X; Wilkinson KD
    Cell; 2006 Mar; 124(6):1197-208. PubMed ID: 16564012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the C-terminus of Saccharomyces cerevisiae ubiquitin-conjugating enzyme (Rad6) in substrate and ubiquitin-protein-ligase (E3-R) interactions.
    Raboy B; Kulka RG
    Eur J Biochem; 1994 Apr; 221(1):247-51. PubMed ID: 8168512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide Arrays for Binding Studies of E3 Ubiquitin Ligases.
    Klecker M; Dissmeyer N
    Methods Mol Biol; 2016; 1450():85-94. PubMed ID: 27424747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A family of mammalian E3 ubiquitin ligases that contain the UBR box motif and recognize N-degrons.
    Tasaki T; Mulder LC; Iwamatsu A; Lee MJ; Davydov IV; Varshavsky A; Muesing M; Kwon YT
    Mol Cell Biol; 2005 Aug; 25(16):7120-36. PubMed ID: 16055722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct identification of ubiquitination sites on ubiquitin-conjugated CHIP using MALDI mass spectrometry.
    Wang D; Xu W; McGrath SC; Patterson C; Neckers L; Cotter RJ
    J Proteome Res; 2005; 4(5):1554-60. PubMed ID: 16212406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanistic insight into the allosteric activation of a ubiquitin-conjugating enzyme by RING-type ubiquitin ligases.
    Ozkan E; Yu H; Deisenhofer J
    Proc Natl Acad Sci U S A; 2005 Dec; 102(52):18890-5. PubMed ID: 16365295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ClpS is an essential component of the N-end rule pathway in Escherichia coli.
    Erbse A; Schmidt R; Bornemann T; Schneider-Mergener J; Mogk A; Zahn R; Dougan DA; Bukau B
    Nature; 2006 Feb; 439(7077):753-6. PubMed ID: 16467841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of ubiquitin lysine mutants to characterize E2-E3 linkage specificity: Mass spectrometry offers a cautionary "tail".
    Hong JH; Ng D; Srikumar T; Raught B
    Proteomics; 2015 Sep; 15(17):2910-5. PubMed ID: 26036340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzyme-substrate relationships in the ubiquitin system: approaches for identifying substrates of ubiquitin ligases.
    O'Connor HF; Huibregtse JM
    Cell Mol Life Sci; 2017 Sep; 74(18):3363-3375. PubMed ID: 28455558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Approach for determining protein ubiquitination sites by MALDI-TOF mass spectrometry.
    Wang D; Cotter RJ
    Anal Chem; 2005 Mar; 77(5):1458-66. PubMed ID: 15732931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Putative E3 ubiquitin ligase of human rotavirus inhibits NF-κB activation by using molecular mimicry to target β-TrCP.
    Morelli M; Dennis AF; Patton JT
    mBio; 2015 Jan; 6(1):. PubMed ID: 25626907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Peptidome Comes of Age: Mass Spectrometry-Based Characterization of the Circulating Cancer Peptidome.
    Greening DW; Kapp EA; Simpson RJ
    Enzymes; 2017; 42():27-64. PubMed ID: 29054270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unraveling the ubiquitin-regulated signaling networks by mass spectrometry-based proteomics.
    Low TY; Magliozzi R; Guardavaccaro D; Heck AJ
    Proteomics; 2013 Feb; 13(3-4):526-37. PubMed ID: 23019148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kaposi's Sarcoma-Associated Herpesvirus LANA Modulates the Stability of the E3 Ubiquitin Ligase RLIM.
    Tadmor H; Greenway M; Ahuja A; Orgil O; Liao G; Ambinder RF; Hayward SD; Shamay M
    J Virol; 2020 Feb; 94(5):. PubMed ID: 31801865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ubiquitination screen using protein microarrays for comprehensive identification of Rsp5 substrates in yeast.
    Gupta R; Kus B; Fladd C; Wasmuth J; Tonikian R; Sidhu S; Krogan NJ; Parkinson J; Rotin D
    Mol Syst Biol; 2007; 3():116. PubMed ID: 17551511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting E3 ubiquitin ligases for cancer therapy.
    Sun Y
    Cancer Biol Ther; 2003; 2(6):623-9. PubMed ID: 14688465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.